642 related articles for article (PubMed ID: 16670102)
21. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Baskind NE; Balen AH
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
[TBL] [Abstract][Full Text] [Related]
22. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
Balen A
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
[TBL] [Abstract][Full Text] [Related]
23. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.
Hall JE; Taylor AE; Hayes FJ; Crowley WF
J Endocrinol Invest; 1998 Oct; 21(9):602-11. PubMed ID: 9856414
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
[TBL] [Abstract][Full Text] [Related]
25. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
26. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
Levin JH; Carmina E; Lobo RA
Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
[TBL] [Abstract][Full Text] [Related]
27. Hypothalamic dysfunction.
Marshall JC; Eagleson CA; McCartney CR
Mol Cell Endocrinol; 2001 Oct; 183(1-2):29-32. PubMed ID: 11604221
[TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome in adolescence.
Blank SK; Helm KD; McCartney CR; Marshall JC
Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
30. [Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].
Wikiera B; Wasikowa R
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):13-8. PubMed ID: 16704856
[TBL] [Abstract][Full Text] [Related]
31. LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.
Hohmann FP; Laven JS; Mulders AG; Oberyé JJ; Mannaerts BM; de Jong FH; Fauser BC
J Endocrinol Invest; 2005 Dec; 28(11):990-7. PubMed ID: 16483177
[TBL] [Abstract][Full Text] [Related]
32. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
33. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
[TBL] [Abstract][Full Text] [Related]
34. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.
Chhabra S; McCartney CR; Yoo RY; Eagleson CA; Chang RJ; Marshall JC
J Clin Endocrinol Metab; 2005 May; 90(5):2810-5. PubMed ID: 15728200
[TBL] [Abstract][Full Text] [Related]
35. Hypothesis: aberrant puberty and the Stein-Leventhal syndrome.
Mechanick JI; Futterweit W
Int J Fertil; 1984; 29(1):35-8. PubMed ID: 6146582
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.
Moore AM; Prescott M; Marshall CJ; Yip SH; Campbell RE
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):596-601. PubMed ID: 25550522
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator.
Foecking EM; Szabo M; Schwartz NB; Levine JE
Biol Reprod; 2005 Jun; 72(6):1475-83. PubMed ID: 15744016
[TBL] [Abstract][Full Text] [Related]
38. Pathological pulses in PCOS.
Coyle C; Campbell RE
Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
[TBL] [Abstract][Full Text] [Related]
39. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
Abbott DH; Barnett DK; Bruns CM; Dumesic DA
Hum Reprod Update; 2005; 11(4):357-74. PubMed ID: 15941725
[TBL] [Abstract][Full Text] [Related]
40. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
